{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:41:04Z","timestamp":1769600464409,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400652"],"award-info":[{"award-number":["81400652"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jss.2016.08.086","type":"journal-article","created":{"date-parts":[[2016,9,10]],"date-time":"2016-09-10T01:26:08Z","timestamp":1473470768000},"page":"211-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Criteria derived from serum markers can precisely evaluate axillary status in breast cancer patients"],"prefix":"10.1016","volume":"208","author":[{"given":"Hangyu","family":"Wan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenggui","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanyi","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"L\u00fc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2016.08.086_bib1","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1002\/cncr.26683","article-title":"Routine clinical use of the one-step nucleic acid amplification assay for detection of sentinel lymph node metastases in breast cancer patients: results of a multicenter study in Japan","volume":"118","author":"Tamaki","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2016.08.086_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1097-0142(19800701)46:1<1::AID-CNCR2820460102>3.0.CO;2-3","article-title":"Findings from NSABP Protocol No. B-04-comparison of radical mastectomy with alternative treatments for primary breast cancer. I. Radiation compliance and its relation to treatment outcome","volume":"46","author":"Fisher","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2016.08.086_bib3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10549-010-1167-6","article-title":"A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance","volume":"125","author":"Wernicke","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jss.2016.08.086_bib4","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/bjs.9955","article-title":"Two decades of axillary management in breast cancer","volume":"102","author":"Beek","year":"2015","journal-title":"Br J Surg"},{"key":"10.1016\/j.jss.2016.08.086_bib5","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jss.2016.08.086_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejso.2011.01.011","article-title":"Accuracy of sentinel lymph node biopsy in large and multifocal\/multicentric breast carcinoma\u2013a systematic review","volume":"37","author":"Spillane","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jss.2016.08.086_bib7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.seminoncol.2004.03.007","article-title":"Nuclear medicine aspects of melanoma and breast lymphatic mapping","volume":"31","author":"Uren","year":"2004","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jss.2016.08.086_bib8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1072-7515(01)00798-0","article-title":"National practice patterns of sentinel lymph node dissection for breast carcinoma","volume":"192","author":"Lucci","year":"2001","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jss.2016.08.086_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/bjs.9390","article-title":"Blue dye is sufficient for sentinel lymph node biopsy in breast cancer","volume":"101","author":"Ang","year":"2014","journal-title":"Br J Surg"},{"key":"10.1016\/j.jss.2016.08.086_bib10","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.amjsurg.2013.07.007","article-title":"Rural and urban disparities in the evolution of sentinel lymph node utilization in breast cancer","volume":"206","author":"Arrington","year":"2013","journal-title":"Am J Surg"},{"key":"10.1016\/j.jss.2016.08.086_bib11","first-page":"234","article-title":"Low axillary sampling in clinically node-negative operable breast cancer","volume":"22","author":"Parmar","year":"2009","journal-title":"Natl Med J India"},{"key":"10.1016\/j.jss.2016.08.086_bib12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/1553350611409063","article-title":"Adoption of surgical innovations: factors influencing use of sentinel lymph node biopsy for breast cancer","volume":"18","author":"Wright","year":"2011","journal-title":"Surg Innov"},{"key":"10.1016\/j.jss.2016.08.086_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.suronc.2006.11.003","article-title":"Lymphedema following axillary lymph node dissection for breast cancer","volume":"15","author":"Sakorafas","year":"2006","journal-title":"Surg Oncol"},{"key":"10.1016\/j.jss.2016.08.086_bib14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0002-9610(01)00602-X","article-title":"Axillary web syndrome after axillary dissection","volume":"181","author":"Moskovitz","year":"2001","journal-title":"Am J Surg"},{"key":"10.1016\/j.jss.2016.08.086_bib15","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jss.2016.08.086_bib16","doi-asserted-by":"crossref","first-page":"7135","DOI":"10.1158\/0008-5472.CAN-09-1618","article-title":"Epithelial-mesenchymal transition and cell cooperativity in metastasis","volume":"69","author":"Tsuji","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2016.08.086_bib17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ctrv.2011.11.001","article-title":"Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact","volume":"38","author":"Foroni","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jss.2016.08.086_bib18","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1158\/0008-5472.CAN-07-2225","article-title":"A human breast cell model of preinvasive to invasive transition","volume":"68","author":"Rizki","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2016.08.086_bib19","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1158\/0008-5472.CAN-13-2994","article-title":"EGFR activation and signaling\u00a0in cancer cells are enhanced by the membrane-bound metalloprotease MT4-MMP","volume":"74","author":"Paye","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2016.08.086_bib20","doi-asserted-by":"crossref","DOI":"10.3791\/4084","article-title":"Conversion of a capture ELISA to a Luminex xMAP assay using a multiplex antibody screening method","author":"Baker","year":"2012","journal-title":"J Vis Exp"},{"key":"10.1016\/j.jss.2016.08.086_bib21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jri.2005.03.005","article-title":"Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants","volume":"66","author":"dupont","year":"2005","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.jss.2016.08.086_bib22","doi-asserted-by":"crossref","first-page":"e992222","DOI":"10.4161\/2162402X.2014.992222","article-title":"A phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer","volume":"4","author":"Eiro","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jss.2016.08.086_bib23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-015-0408-z","article-title":"Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival","volume":"14","author":"Farooqui","year":"2015","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jss.2016.08.086_bib24","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1158\/0008-5472.CAN-09-0187","article-title":"Blockade of PAR1 signaling\u00a0with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses\u00a0tumor survival and metastasis","volume":"69","author":"Yang","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2016.08.086_bib25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12943-015-0389-y","article-title":"HGF and TGFbeta1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells","volume":"14","author":"Bendinelli","year":"2015","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jss.2016.08.086_bib26","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.ejca.2010.02.036","article-title":"Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor\/Met and beta-catenin\/Wnt pathways","volume":"46","author":"Previdi","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jss.2016.08.086_bib27","doi-asserted-by":"crossref","first-page":"39050","DOI":"10.18632\/oncotarget.5176","article-title":"RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration","volume":"6","author":"Datar","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jss.2016.08.086_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1593\/neo.111122","article-title":"Mechanisms regulating the secretion of the promalignancy chemokine\u00a0CCL5 by breast tumor cells: CCL5's 40s loop and\u00a0intracellular glycosaminoglycans","volume":"14","author":"Soria","year":"2012","journal-title":"Neoplasia"},{"key":"10.1016\/j.jss.2016.08.086_bib29","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.4081\/oncol.2012.e20","article-title":"Axillary dissection compared to sentinel node biopsy for the treatment of pathologically node-negative breast cancer: a meta-analysis of four randomized trials with long-term follow up","volume":"6","author":"Petrelli","year":"2012","journal-title":"Oncol Rev"},{"key":"10.1016\/j.jss.2016.08.086_bib30","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10549-011-1665-1","article-title":"Sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis","volume":"129","author":"Wang","year":"2011","journal-title":"Breast Cancer Res Treat"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480416303602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480416303602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T10:34:01Z","timestamp":1568370841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480416303602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":30,"alternative-id":["S0022480416303602"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2016.08.086","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Criteria derived from serum markers can precisely evaluate axillary status in breast cancer patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2016.08.086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}